# Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

> **NCT01081574** · PHASE1,PHASE2 · COMPLETED · sponsor: **Faes Farma, S.A.** · enrollment: 36 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis
- Chronic Urticaria

## Interventions

- **DRUG:** Bilastine

## Key facts

- **NCT ID:** NCT01081574
- **Lead sponsor:** Faes Farma, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081574, "Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01081574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*